Table 2.

Significant levels of Cytokines and Peptides combined in pilot study.

Cytokines and Peptides Combined	LTBI	ATBD	p-Value *
Rv0849-12
IL-1RA	0.48 (0.0–1.87)	5.57 (0.0–84.45)	0.001
IP-10	8.72 (0.0–15.01)	1.09 (0.0–10.60)	0.054
MCP-1	46.87 (0.0–408.52)	361.73 (48.60–1447.92)	0.003
Rv2031c-14
IL-1RA	0.51 (0.0–1.18)	13.55 (0.26–73.2)	0.001
Rv2031c-5
IL-1RA	0.47 (0.0–1.42)	4.51 (0.0–84.50)	0.006
IL-8	189.6 (26.91–441.22)	368.65 (92.22–1611.75)	0.041
MCP-3	14.13 (2.23–45.15)	30.53 (9.46–132.49)	0.033
GRO	45.57 (8.05–139.76)	105.35 (21.05–579.55)	0.017
EGF	1.57 (0.0–6.71)	7.78 (0.0–28.99)	0.030
Rv2693-06
IL-1RA	0.06 (0.0–1.87)	4.78 (0.0–69.27)	0.001
IL-8	168.23 (43.61–368.22)	266.01 (123.42–1031.04)	0.038
MCP-1	42.15 (0.0–656.25)	468.47 (0.0–1689.57)	0.029
GRO	33.11 (9.28–94.95)	77.50 (21.21–259.76)	0.036
EGF	0 (0.0–4.95)	6.17 (0.0–22.15)	0.001
MDC	0 (0.0–7.26)	6.80 (0.0–27.95)	0.002
IL-13	0 (0.0–2.08)	1.68 (0.0–3.94)	0.022

Median (Q1–Q3), * Mann–Whitney test, Number of samples = 30.